Cardiac and vascular pathophysiology in hypertension.
作者信息
Mayet Jamil, Hughes Alun
机构信息
International Centre for Circulatory Health, 10th Floor QEQM Wing, St Mary's Hospital, and Imperial College Paddington and Clinical Pharmacology, NHLI, Imperial College of Science, Technology & Medicine, London, UK.
出版信息
Heart. 2003 Sep;89(9):1104-9. doi: 10.1136/heart.89.9.1104.
Abstract
摘要
相似文献
1
Cardiac and vascular pathophysiology in hypertension.
Heart. 2003 Sep;89(9):1104-9. doi: 10.1136/heart.89.9.1104.
2
[Effect of complex sanatorium treatment including magnetotherapy on hemodynamics in patients with arterial hypertension].
Vopr Kurortol Fizioter Lech Fiz Kult. 2003 May-Jun(3):9-12.
3
Pathophysiology of aortic cross-clamping.
Acta Anaesthesiol Scand Suppl. 1997;110:41-2. doi: 10.1111/j.1399-6576.1997.tb05494.x.
4
Intravital Observation of Microvascular Remodeling During Chronic Exposure to Hypoxia in Mice.
Adv Exp Med Biol. 2018;1072:245-249. doi: 10.1007/978-3-319-91287-5_39.
5
6
Quantification of the contribution of cardiac and arterial remodeling to hypertension.
Hypertension. 2000 Nov;36(5):760-5. doi: 10.1161/01.hyp.36.5.760.
7
Reappraisal of the Cushing reflex: the most powerful neural blood pressure stabilizing system.
Clin Sci (Lond). 1990 Dec;79(6):543-50. doi: 10.1042/cs0790543.
8
Clinical studies on peripheral hemodynamics in arterial hypertension.
Angiology. 1976 Jul-Aug;27(7):422-32. doi: 10.1177/000331977602700702.
9
[Left ventricular function in essential arterial hypertension: a difficult research area].
G Ital Cardiol. 1980;10(5):490-3.
10
Contribution of increased minimal coronary resistance and attenuated vascular adaptive remodeling to myocardial ischemia in patients with systemic hypertension and ventricular hypertrophy.
Am J Cardiol. 2004 Aug 15;94(4):484-7. doi: 10.1016/j.amjcard.2004.04.064.
引用本文的文献
1
Multiple Model Predictive Control of the Cardiovascular System using Vagal Nerve Stimulation.
IEEE Trans Control Syst Technol. 2025 Jan;33(1):400-407. doi: 10.1109/tcst.2024.3473772. Epub 2024 Oct 16.
2
Circulating Extracellular Vesicles in Cardiovascular Disease.
Int J Mol Sci. 2025 Jul 16;26(14):6817. doi: 10.3390/ijms26146817.
3
Radiation-Induced Cardiotoxicity in Hypertensive Salt-Sensitive Rats: A Feasibility Study.
Life (Basel). 2025 May 27;15(6):862. doi: 10.3390/life15060862.
4
Blunted cardiovascular responses in individuals with type 2 diabetes and hypertension during cold and heat exposure.
Front Physiol. 2025 Apr 28;16:1558471. doi: 10.3389/fphys.2025.1558471. eCollection 2025.
5
Lead-Free Potassium Sodium Niobate-Based Wearable Ultrasonic Patches for Blood Pressure Detection.
Micromachines (Basel). 2025 Mar 28;16(4):392. doi: 10.3390/mi16040392.
6
Effect of amphetamines on blood pressure.
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD007896. doi: 10.1002/14651858.CD007896.pub4.
7
Solid Lipid Nanoparticles for the Management of Hypertension: Advancements and Challenges.
Curr Pharm Des. 2025;31(23):1823-1843. doi: 10.2174/0113816128337166241219081400.
8
Systematic evaluation of single-cell multimodal data integration for comprehensive human reference atlas.
bioRxiv. 2025 Mar 6:2025.03.06.637075. doi: 10.1101/2025.03.06.637075.
9
Application of a ImageJ-Based Method to Measure Blood Flow in Adult Zebrafish and Its Applications for Toxicological and Pharmacological Assessments.
Biology (Basel). 2025 Jan 10;14(1):51. doi: 10.3390/biology14010051.
10
Hypertensive Response to Exercise in Normotensive Men and Women with Abdominal Obesity: Association with Subclinical Adverse Cardiac Remodeling.
J Clin Med. 2024 Dec 24;14(1):16. doi: 10.3390/jcm14010016.
本文引用的文献
1
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
2
Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction.
Circulation. 2002 Mar 12;105(10):1195-201. doi: 10.1161/hc1002.105185.
3
Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
Hypertension. 2000 Nov;36(5):755-9. doi: 10.1161/01.hyp.36.5.755.
4
Impact of arterial stiffening on left ventricular structure.
Hypertension. 2000 Oct;36(4):489-94. doi: 10.1161/01.hyp.36.4.489.
5
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.
J Am Coll Cardiol. 1999 Jun;33(7):1948-55. doi: 10.1016/s0735-1097(99)00118-7.
6
Arterial remodeling: relation to hemodynamics.
Can J Physiol Pharmacol. 1996 Jul;74(7):834-41.
7
Left ventricular hypertrophy and QT dispersion in hypertension.
Hypertension. 1996 Nov;28(5):791-6. doi: 10.1161/01.hyp.28.5.791.
8
Small artery structure in hypertension. Dual processes of remodeling and growth.
Hypertension. 1993 Apr;21(4):391-7. doi: 10.1161/01.hyp.21.4.391.
9
Structural changes in the heart and carotid arteries associated with hypertension in humans.
J Hum Hypertens. 1993 Aug;7(4):395-7.
10
This day 50 years ago.
N Engl J Med. 1995 Apr 13;332(15):1038-9. doi: 10.1056/NEJM199504133321518.
Zotero 插件